Seneca Therapeutics

BLUE BELL, PA · Health Care · 10 employees

Seneca Therapeutics was found by Dr. Paul Hallenbeck to develop the Seneca Valley Virus (“SVV-001”), a best in class oncolytic virus. SVV-001 is already in Phase I/II and has a clinical safety record in humans. SVV-001 binds to the TEM8 receptor which is common in many solid tumors like breast cancer, lung cancer and neuroendocrine tumors. SVV-001 is also being considered as a viral vector for gen

See plans & pricing → Track Seneca Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.